Literature DB >> 18982250

Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations?

Luca Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni, Pamela Vezzoli, Silvia Fargion.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18982250     DOI： 10.1007/s11739-008-0199-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  8 in total

1.  Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria.

Authors:  A Grieco; B Alfei; P Di Rocco; L Miele; G Biolcati; D Griso; F M Vecchio; A Bianco; G Gasbarrini
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-08       Impact factor: 2.566

Review 2.  Prevalence of hepatitis C virus infection in porphyria cutanea tarda.

Authors:  Silvia Fargion; Anna Ludovica Fracanzani
Journal:  J Hepatol       Date:  2003-10       Impact factor: 25.083

3.  HFE mutations in nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Paola Dongiovanni; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

4.  Hemochromatosis and iron-overload screening in a racially diverse population.

Authors:  Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

5.  High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.

Authors:  M Sampietro; A Piperno; L Lupica; C Arosio; A Vergani; N Corbetta; I Malosio; M Mattioli; A L Fracanzani; M D Cappellini; G Fiorelli; S Fargion
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

6.  Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

Authors:  L Valenti; P Dongiovanni; A L Fracanzani; G Santorelli; E Fatta; C Bertelli; E Taioli; G Fiorelli; S Fargion
Journal:  Dig Liver Dis       Date:  2003-03       Impact factor: 4.088

7.  Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.

Authors:  Elisabetta Bugianesi; Paola Manzini; Sergio D'Antico; Ester Vanni; Filomena Longo; Nicola Leone; Paola Massarenti; Antonio Piga; Giulio Marchesini; Mario Rizzetto
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

8.  Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.

Authors:  Elmar Aigner; Igor Theurl; Milan Theurl; Dieter Lederer; Heike Haufe; Otto Dietze; Michael Strasser; Christian Datz; Guenter Weiss
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045
  8 in total
  1 in total

1.  Porphyria cutanea tarda associated with HFE C282Y homozygosity, iron overload, and use of a contraceptive vaginal ring.

Authors:  James C Barton; Corwin Q Edwards
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.